Morphine-induced antinociception in the rat: Supra-additive interactions with imidazoline I 2 receptor ligands

European Journal of Pharmacology

Volumn 669, Issue 1-3, 2011, Pages 59-65

  Li, Jun Xu ^a   Zhang, Yanan ^b   Winter, Jerrold C ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Antinociception; Imidazoline I 2 receptor; Morphine; Writhing test

Indexed keywords

2 (2 BENZOFURANYL) 2 IMIDAZOLINE; 2 (2 IMIDAZOLIN 2 YL)QUINOLINE; AGMATINE; IDAZOXAN; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I2 RECEPTOR; MORPHINE; OPIATE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DETERMINATION; DRUG INHIBITION; DRUG STRUCTURE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; TREATMENT RESPONSE; WRITHING TEST;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; AGMATINE; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; BENZOFURANS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; IDAZOXAN; IMIDAZOLES; IMIDAZOLINE RECEPTORS; LIGANDS; MALE; MORPHINE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; SALINE SOLUTION, HYPERTONIC; YOHIMBINE;

EID: 80053312268     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.07.041     Document Type: Article

References (43)

1. S. Aggarwal, B. Shavalian, E. Kim, and S.M. Rawls Agmatine enhances cannabinoid action in the hot-plate assay of thermal nociception Pharmacol. Biochem. Behav. 93 2009 426 432
2. L. Annemans Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent pain Clin. Drug Investig. 31 2011 73 86
3. R. Berkels, D. Taubert, D. Grundemann, and E. Schomig Agmatine signaling: odds and threads Cardiovasc. Drug Rev. 22 2004 7 16 (Pubitemid 38375050)
4. M.A. Boronat, G. Olmos, and J.A. Garcia-Sevilla Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands Br. J. Pharmacol. 125 1998 175 185 (Pubitemid 28418770)
5. P. Bousquet, J. Feldman, and J. Schwartz Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines J. Pharmacol. Exp. Ther. 230 1984 232 236 (Pubitemid 14097683)
6. H.O. Collier, L.C. Dinneen, C.A. Johnson, and C. Schneider The abdominal constriction response and its suppression by analgesic drugs in the mouse Br. J. Pharmacol. Chemother. 32 1968 295 310
7. C.A. Fairbanks, L.S. Stone, and G.L. Wilcox Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis Pharmacol. Ther. 123 2009 224 238
8. K. Fukawa, O. Kawano, M. Hibi, N. Misaki, S. Ohba, and Y. Hatanaka A method for evaluating analgesic agents in rats J. Pharmacol. Methods 4 1980 251 259 (Pubitemid 11232113)
9. J.A. Garcia-Sevilla, P.V. Escriba, and J. Guimon Imidazoline receptors and human brain disorders Ann. N. Y. Acad. Sci. 881 1999 392 409 (Pubitemid 29349535)
10. F. Gentili, C. Cardinaletti, A. Carrieri, F. Ghelfi, L. Mattioli, M. Perfumi, C. Vesprini, and M. Pigini Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects Eur. J. Pharmacol. 553 2006 73 81 (Pubitemid 44779586)
11. A. Halaris, and J. Plietz Agmatine: metabolic pathway and spectrum of activity in brain CNS Drugs 21 2007 885 900 (Pubitemid 47557104)
12. G.A. Head, and D.N. Mayorov Imidazoline receptors, novel agents and therapeutic potential Cardiovasc. Hematol. Agents Med. Chem. 4 2006 17 32 (Pubitemid 43796697)
13. A.L. Hudson, R. Gough, R. Tyacke, L. Lione, M. Lalies, J. Lewis, S. Husbands, P. Knight, F. Murray, P. Hutson, and D.J. Nutt Novel selective compounds for the investigation of imidazoline receptors Ann. N. Y. Acad. Sci. 881 1999 81 91 (Pubitemid 29349492)
14. A.L. Hudson, R.J. Tyacke, M.D. Lalies, N. Davies, D.P. Finn, O. Marti, E. Robinson, S. Husbands, M.C. Minchin, A. Kimura, and D.J. Nutt Novel ligands for the investigation of imidazoline receptors and their binding proteins Ann. N. Y. Acad. Sci. 1009 2003 302 308 (Pubitemid 38265124)
15. M. Ishihara, and H. Togo Direct oxidative conversion of aldehydes and alcohols to 2-imidazolines and 2-oxazolines using molecular iodine Tetrahedron 63 2007 1474 1480 (Pubitemid 44969407)
16. S.B. Jou, I.M. Liu, and J.T. Cheng Activation of imidazoline receptor by agmatine to lower plasma glucose in streptozotocin-induced diabetic rats Neurosci. Lett. 358 2004 111 114
17. Y. Kolesnikov, S. Jain, and G.W. Pasternak Modulation of opioid analgesia by agmatine Eur. J. Pharmacol. 296 1996 17 22 (Pubitemid 26032232)
18. D. Le Bars, M. Gozariu, and S.W. Cadden Animal models of nociception Pharmacol. Rev. 53 2001 597 652 (Pubitemid 33136239)
19. J.X. Li, and Y. Zhang Imidazoline I(2) receptors: target for new analgesics? Eur. J. Pharmacol. 658 2011 49 56
20. G. Li, S. Regunathan, C.J. Barrow, J. Eshraghi, R. Cooper, and D.J. Reis Agmatine: an endogenous clonidine-displacing substance in the brain Science 263 1994 966 969 (Pubitemid 24094560)
21. J. Li, X. Li, G. Pei, and B.Y. Qin Analgesic effect of agmatine and its enhancement on morphine analgesia in mice and rats Zhongguo Yao Li Xue Bao 20 1999 81 85 (Pubitemid 29042469)
22. J.X. Li, C. Crocker, W. Koek, K.C. Rice, and C.P. France Effects of serotonin (5-HT)1A and 5-HT2A receptor agonists on schedule-controlled responding in rats: drug combination studies Psychopharmacology (Berl) 213 2011 489 497
23. J.X. Li, W. Koek, K.C. Rice, and C.P. France Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys Neuropsychopharmacology 36 2011 940 949
24. L.A. Lione, D.J. Nutt, and A.L. Hudson Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors Eur. J. Pharmacol. 353 1998 123 135 (Pubitemid 28352298)
25. J.T. Litchfield Jr., and F. Wilcoxon A simplified method of evaluating dose-effect experiments J. Pharmacol. Exp. Ther. 96 1949 99 113
26. R.H. Loring Agmatine acts as an antagonist of neuronal nicotinic receptors Br. J. Pharmacol. 99 1990 207 211 (Pubitemid 20033812)
27. N. Macinnes, and S. Duty Locomotor effects of imidazoline I2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway Br. J. Pharmacol. 143 2004 952 959 (Pubitemid 40065495)
28. M.J. Millan Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice Pain 58 1994 45 61
29. S. Newsome, B.K. Frawley, and C.E. Argoff Intrathecal analgesia for refractory cancer pain Curr. Pain Headache Rep. 12 2008 249 256
30. H.O. Nguyen, C.J. Goracke-Postle, L.L. Kaminski, A.C. Overland, A.D. Morgan, and C.A. Fairbanks Neuropharmacokinetic and dynamic studies of agmatine (decarboxylated arginine) Ann. N. Y. Acad. Sci. 1009 2003 82 105 (Pubitemid 38265093)
31. R.B. Raffa, D.J. Stone Jr., and R.J. Tallarida Discovery of "self-synergistic" spinal/supraspinal antinociception produced by acetaminophen (paracetamol) J. Pharmacol. Exp. Ther. 295 2000 291 294
32. S.M. Rawls, M. Amin, and J. Zisk Agmatine blocks morphine-evoked hyperthermia in rats Brain Res. 1147 2007 89 94 (Pubitemid 46584659)
33. S. Regunathan, and D.J. Reis Imidazoline receptors and their endogenous ligands Annu. Rev. Pharmacol. Toxicol. 36 1996 511 544 (Pubitemid 26168708)
34. S.C. Roerig Spinal and supraspinal agmatine activate different receptors to enhance spinal morphine antinociception Ann. N. Y. Acad. Sci. 1009 2003 116 126 (Pubitemid 38265095)
35. P. Sanchez-Blazquez, M.A. Boronat, G. Olmos, J.A. Garcia-Sevilla, and J. Garzon Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors Br. J. Pharmacol. 130 2000 146 152 (Pubitemid 30248438)
36. D.A. Sica Centrally acting antihypertensive agents: an update J. Clin. Hypertens. (Greenwich) 9 2007 399 405
37. H.S. Smith Combination opioid analgesics Pain Physician 11 2008 201 214 (Pubitemid 351546231)
38. G.W. Stevenson, J.E. Folk, K.C. Rice, and S.S. Negus Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5- dimethyl-1-piperazinyl)-3-meth oxybenzyl]-N,N-diethylbenzamide] and heroin J. Pharmacol. Exp. Ther. 314 2005 221 231 (Pubitemid 41058259)
39. C.H. Su, I.M. Liu, H.H. Chung, and J.T. Cheng Activation of I2-imidazoline receptors by agmatine improved insulin sensitivity through two mechanisms in type-2 diabetic rats Neurosci. Lett. 457 2009 125 128
40. R.J. Tallarida Drug Synergism and Dose-Effect Data Analysis 2000 Chapman and Hall/CRC Boca Raton
41. J.C. Winter, and R.A. Rabin Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination J. Pharmacol. Exp. Ther. 263 1992 682 689
42. N. Wu, R.B. Su, and J. Li Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence Cell. Mol. Neurobiol. 28 2008 629 641 (Pubitemid 351905063)
43. J. Zacny, G. Bigelow, P. Compton, K. Foley, M. Iguchi, and C. Sannerud College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement Drug Alcohol Depend. 69 2003 215 232 (Pubitemid 36293934)